p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin- regulated signals for E2F regulation in T lymphocytes

Molecular and Cellular Biology

Volumn 19, Issue 7, 1999, Pages 4729-4738

  Brennan, Paul ^a   Babbage, J W ^a   Thomas, G ^b   Cantrell, Doreen ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; S6 KINASE; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE; ENZYME ACTIVITY; ENZYME REGULATION; GENE CONTROL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0033000334     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.7.4729     Document Type: Article

References (47)

1. Beadling, C., D. Guschin, B. A. Witthuhn, A. Ziemiecki, J. N. Ihle, I. M. Kerr, and D. A. Cantrell. 1994. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon-α, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13:5605-5615.
2. Beadling, C., J. Ng, J. W. Babbage, and D. A. Cantrell. 1996. Interleukin-2 activation of STATS requires the convergent action of tyrosine kinases and a serine/threonine kinase distinct from the Raf-1/Erk2 MAP kinase pathway. EMBO J. 15:1902-1913.
3. Beretta, L., A. C. Gingras, Y. V. Svitkin, M. N. Hall, and N. Sonenberg. 1996. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15:658-664.
4. Botz, J., K. Zerfass-Thome, D. Spitzovsky, H. Delius, B. Vogt, M. Eilers, A. Hatzigeorgiou, and P. Jansen-Durr. 1996. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16:3401-3409.
5. Brennan, P., J. W. Babbage, B. M. T. Burgering, B. Groner, K. Reif, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase controls E2F transcriptional activity in response to interleukin-2. Immunity 7:679-689.
6. Brown, E. J., M. W. Albers, T. B. Shin, K. Ichikawa, C. T. Keith, W. S. Lane, and S. L. Schreiber. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369:756-758.
7. Brunn, G. J., C. C. Hudson, A. Sekulic, J. M. Williams, H. Hosoi, P. J. Houghton, J. C. J. Lawrence, and R. T. Abraham. 1997. Phosphorylation of the translational repressor PHAS-1 by the mammalian target of rapamycin. Science 277:99-101.
8. Cantrell, D. A., and K. A. Smith. 1984. The interleukin-2 T-cell system: a new cell growth model. Science 224:1312-1316.
9. Chen, Y., E. S. Knudsen, and J. Y. Wang. 1996. The RB/p107/p130 phosphorylation pathway is not inhibited in rapamycin-induced G1-prolongation of NIH3T3 cells. Oncogene 13:1765-1771.
10. Dennis, P. B., S. Fumagalli, and G. Thomas. 1999. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr. Opin. Genet. Dev. 9:49-54.
11. Fairhurst, R. M., M. Daeipour, M. C. Amaral, and A. E. Nel. 1993. Activation of mitogen-activated protein kinase/ERK-2 in phytohaemagglutinin in blasts by recombinant interleukin-2: contrasting features with CD3 activation. Immunology 79:112-118.
12. Genot, E. M., P. J. Parker, and D. A. Cantrell. 1995. Analysis of the role of the protein kinase Cα, ∈, and ζ in T cell activation. J. Biol. Chem. 270:9833-9839.
13. Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. Oncogene 7:693-701.
14. Hashemolhosseini, S., Y. Nagamine, S. J. Morley, S. Desrivières, L. Mercep, and S. Ferrari. 1998. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J. Biol. Chem. 273:14424-14429.
15. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28-35.
16. Hori, T., T. Uchiyama, M. Tsudo, H. Umadome, H. Ohno, S. Fukuhara, K. Kita, and H. Uchino. 1987. Establishment of an interleukin-2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 70:1069-1072.
17. Hou, J., U. Schindler, W. J. Henzel, S. C. Wong, and S. L. McKnight. 1995. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2:321-329.
18. Izquierdo Pastor, M., K. Reif, and D. Cantrell. 1995. The regulation and function of p21ras during T-cell activation and growth. Immunol. Today 16:159-164.
19. Jefferies, H. B., S. Fumagalli, P. B. Dennis, C. Reinhard, R. B. Pearson, and G. Thomas. 1997. Rapamycin suppresses 5́TOP mRNA translation through inhibition of p70s6k. EMBO J. 16:3693-3704.
20. Johnston, J., M. Kawamura, R. Kirken, Y. Chen, T. Blake, K. Shibuya, J. Ortaldo, D. McVicar, and J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151-153.
21. Johnston, J. A., C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan, K. Shibuya, J. R. Ortaldo, S. Gupta, Y. Q. Chen, J. D. Giri, and J. O'Sbea. 1995. Tyrosine phosphorylation and activation of Stat5, Stat3, and Janus kinases by interleukin-2 and interleukin-15. Proc. Natl. Acad. Sci. USA 92:8705-8709.
22. Karnitz, L. M., L. A. Burns, S. L. Sutor, J. Blenis, and R. T. Abraham. 1995. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol. 15:3049-3057.
23. Kawasame, H., P. Papst, S. Webb, G. M. Keller, G. L. Johnson, E. W. Gelfand, and N. Terada. 1998. Targeted disruption of p70S6k defines its role in protein synthesis and rapamycin sensitivity. Proc. Natl. Acad. Sci. USA 95:5033-5038.
24. Lin, J.-X., T.-S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, and W. J. Leonard. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-339.
25. Loeken, M. R., and J. Brady. 1989. The adenovirus EIIA enhancer. Analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection. J. Biol. Chem. 264:6572-6579.
26. Mann, D. J., and N. C. Jones. 1996. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr. Biol. 6:474-483.
27. Meyuhas, O., D. Avni, and S. Shama. 1996. Translational control of ribosomal protein mRNAs in eukaryotes, p. 363-388. In J. W. B. Hershey, M. B. Matthews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
28. Ming, X.-F., B. M. T. Burgering, S. Wennström, L. Claesson-Welsh, C.-H. Heldin, J. L. Bos, S. C. Kozma, and G. Thomas. 1994. Activation of p70/p85 S6 kinase by a pathway independent of p21ras. Nature 371:426-429.
29. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z.-J. Liu, I. Oishi, O. Silvennoinen, B. Witthuhn, J. Ihle, and T. Taniguchi. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045-1047.
30. Moberg, K., M. A. Starz, and J. A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436-1449.
31. Murthy, S. C., G. P. Bhat, and B. Thimmappaya. 1985. Adenovirus EIIA early promoter: transcriptional control elements and induction by the viral pre-early EIA gene, which appears to be sequence independent. Proc. Natl. Acad. Sci. USA 82:2230-2234.
32. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts. 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
33. Ohtani, K., and J. R. Nevins. 1994. Functional properties of a Drosophila homolog of the E2F1 gene. Mol. Cell. Biol. 14:1603-1612.
34. Reif, K., B. M. T. Burgering, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 272:14426-14438.
35. Reif, K., C. D. Nobes, G. Thomas, A. Hall, and D. A. Cantrell. 1996. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 6:1445-1455.
36. Remillard, B., R. Petrillo, W. Maslinski, M. Tsudo, T. B. Strom, L. Cantley, and L. Varticovski. 1991. Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 266:14167-14170.
37. Russell, S., J. Johnston, M. Noguchi, M. Kawamura, C. Bacon, M. Friedman, M. Berg, D. McVicar, B. Witthuhn, O. Silvennoinen, A. Goldman, F. Schmalstieg, J. Ihle, J. O'Shea, and W. Leonard. 1994. Interaction of IL-2R β and γ chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042-1045.
38. Sabatini, D. M., H. Erdjumentbromage, M. Lui, P. Tempst, and S. H. Snyder. 1994. Raft1 - a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast Tors. Cell 78:35-43.
39. Sheaff, R. J., M. Groudine, M. Gordon, J. M. Roberts, and B. E. Clurman. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1464-1478.
40. Shi, Y., R. Wang, A. Sharma, C. Gao, M. Collins, L. Penn, and G. B. Mills. 1997. Dissociation of cytokine signals for proliferation and apoptosis. J. Immunol. 159:5318-5328.
41. Shima, H., M. Pende, Y. Chem, S. Fumagalli, G. Thomas, and S. C. Kozma. 1998. Disruption of the p70S6k/p85S6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17:6649-6659.
42. Smith, K. A., and D. A. Cantrell. 1985. Interleukin 2 regulates its own receptors. Proc. Natl. Acad. Sci. USA 82:864-868.
43. Terada, N., K. Takase, P. Papst, A. Nairn, and E. Gelfand. 1995. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen activated T lymphocytes. J. Immunol. 155:3418-3426.
44. Thomas, G., and M. N. Hall. 1997. TOR signalling and control of cell growth. Curr. Opin. Cell Biol. 9:782-787.
45. Turner, B., U. Rapp, H. App, M. Greene, K. Dobashi, and J. Reid. 1991. Interleukin-2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in a T cell line. Proc. Natl. Acad. Sci. USA 88:1227-1232.
46. Von Manteuffel, S. R., A. C. Gingras, X. F. Ming, N. Sonenberg, and G. Thomas. 1996. 4E-BP1 phosphorylation is mediated by the Frap-p70 S6 kinase pathway and is independent of mitogen-activated protein-kinase. Proc. Natl. Acad. Sci. USA 93:4076-4080.
47. Witthuhn, B., O. Silvennoinen, O. Miura, K. Lai, C. Cwik, E. Liu, and J. Ihle. 1994. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153-157.